The French diagnostics firm said it will use the funding to support its merger and acquisition strategy.
The company issued more than 1.8 million shares of its common stock to several of its trade creditors to erase debt that it owed them, Precipio said in an SEC document.
The company may use the proceeds of the loans to help fund the $7.2 billion acquisition of Patheon. The loan facility follows a $1.5 billion senior notes offering by Thermo Fisher last week.
The company plans to use the net proceeds to partially fund the $7.2 billion acquisition of pharmaceutical contract development and manufacturing firm Patheon.
GeneNews has signed a binding agreement with multinational private equity firm Milost Global for up to $10 million in equity and debt financing.
Singulex plans to use the investment to continue to develop its single-molecule counting technology.
The company also said it has closed a new $25 million debt facility, and will use the proceeds to retire outstanding debt and bolster the launch of AlloSure.
The firm closed its existing debt facility with Silicon Valley Bank and Oxford Finance and plans to use the funds for general corporate purposes and working capital.
Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.
Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.
In Science this week: research regulation and reporting requirement reform, and more.
With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.